Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0000932352-18-000001
Filing Date
2018-02-07
Accepted
2018-02-07 10:31:02
Documents
1
Effectiveness Date
2018-02-07
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9200
  Complete submission text file 0000932352-18-000001.txt   10503
Mailing Address 675 HIGHWAY ONE, SUITE B-206 NORTH BRUNSWICK NJ 08902
Business Address 675 HIGHWAY ONE, SUITE B-206 NORTH BRUNSWICK NJ 08902 732-640-0160
Urigen Pharmaceuticals, Inc. (Filer) CIK: 0000932352 (see all company filings)

EIN.: 943156660 | State of Incorp.: DE | Fiscal Year End: 0630
Type: D | Act: 33 | File No.: 021-304992 | Film No.: 18579668
SIC: 2834 Pharmaceutical Preparations